Anzeige
Mehr »
Donnerstag, 30.04.2026 - Börsentäglich über 12.000 News
250 Tage bis zum Pentagon-Magnetverbot: Wie ein 46-Mio.-CAD-Small-Cap profitieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von pharmaphorum

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiChiesi signs $1.9bn deal to buy KalVista and its HAE drug
MiAZ will invest £300m in UK, says PM Keir Starmer
MiAmgen, AZ will pilot FDA's real-time clinical trial plan
MiAZ, Amgen will pilot FDA's real-time clinical trial plan
MiFirst-quarter sales strength buoys new GSK CEO Miels
MiUK study finds clue to rising cancer rates in younger people
DiMerck KGaA partners Remepy in PDURS-focused alliance
DiAI start-up Profluent nabs Lilly as first big pharma partner
DiCan Purdue finally get its bankruptcy plan over the line?
DiGSK eyes October FDA verdict on chronic hep B drug
DiNovartis shares fall as Entresto sales weaken
DiBoehringer/Zealand dual-acting drug causes 16.6% weight loss
MoIntellia files CRISPR drug after historic phase 3 readout
MoLilly's M&A team strikes again with $2.3bn Ajax takeover
MoGSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio
MoLilly falls on slower start for Foundayo versus Wegovy
MoNew NIHR-funded TRC for Parkinson's disease
MoSun sets out $11.75bn takeover play for Organon
FrFDA grants three priority vouchers to psychedelics
FrFDA declines to approve AbbVie's Botox follow-up
FrFDA clears first genetic hearing loss gene therapy
23.04.Trump's DOJ reschedules medicinal marijuana, increasing access
23.04.Ray's upscaled Series B, and other biofinancings
23.04.UK Biobank patient data placed on sale in China
23.04.Novo says oral semaglutide works in diabetic kids